Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2003
11/13/2003US20030212273 Pyrrolo [2,3-D] pyrimidine compounds
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212138 Synergistic mixture; analgesics, antiinflammatory agents, cardiovascular disorders, anticancer agents
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212091 Aryl ether substituted imidazoquinolines
11/13/2003US20030212073 Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212057 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
11/13/2003US20030212026 Induce immunology response
11/13/2003US20030212004 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
11/13/2003US20030211986 Protein a compositions and methods of use
11/13/2003US20030211969 Administering activated protein c; controlling blood coagulation
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211113 Administering immunosuppressant
11/13/2003CA2703698A1 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
11/13/2003CA2484983A1 5-ethyl-imidazo (5,1-f) (1,2,4,) triazin-4 (3h) -ones as phosphodiesterase inhibitors
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2484209A1 Protein kinase modulators and methods of use
11/13/2003CA2484065A1 Inhibitors of histone deacetylase
11/13/2003CA2483917A1 Formulations limiting spread of pulmonary infections
11/13/2003CA2483865A1 7-aminoimidazotriazones
11/13/2003CA2483846A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003CA2483806A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003CA2483787A1 Melanocortin receptor ligands
11/13/2003CA2483573A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003WO2003093219A1 NOVEL PHENYLETHANOLAMINE COMPOUNDS HAVING β2-ACCEPTOR EXCITATORY FUNCTION AND THEIR PREPARATION METHOD
11/12/2003EP1361269A1 Delivery of gene products via mesangial cells expressing an exogenous gene
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1360319A2 Diagnosis of diseases associated with metabolism
11/12/2003EP1360304A2 Enzymes
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360186A2 Carboline derivatives
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1360184A1 Piperidinee derivatives as neurokinin 1 antagonists
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360170A1 Carboxylic amides, the production and use thereof as medicaments
11/12/2003EP1359978A2 Methods and devices for use in performing pulmonary procedures
11/12/2003EP1359927A1 Herbal pharmaceutical compositions for treating immunological disorders
11/12/2003EP1359915A1 Urotensin-ii receptor antagonists
11/12/2003EP1359913A1 Thrombin inhibitors
11/12/2003EP1359912A2 Novel methods using pyridine derivatives
11/12/2003EP1359906A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/12/2003EP1359902A2 Bimodal dry powder formulation for inhalation
11/12/2003EP1282614B1 Hydroxamic acid derivatives
11/12/2003EP1240164B1 Benzazole derivatives and their use as jnk modulators
11/12/2003EP1235809B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies
11/12/2003EP1087750B1 Pharmaceutical formulations for aerosols with two or more active substances
11/12/2003EP0996618B1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof
11/12/2003EP0775203B1 Method of gene therapy using dna vectors without selection marker gene
11/12/2003CN1455779A Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455663A Novel aerosol formulation containing polar fluorinated molecule
11/12/2003CN1454888A Rapid-dissoved ambroxol salt and preparing method thereof
11/12/2003CN1454666A Medicine composition, preparing method thereof and its use for preparing medicines for curing SARS and SARS-induced cardio-cerebro complication
11/12/2003CN1454665A Chinese medicine for preventing and curing SARS cirus
11/12/2003CN1454655A Medicine for curing rheumatoid disease and chronic bronchitis and preparing method thereof
11/12/2003CN1454623A Chinese medicine for curing pharynx and larynx disease
11/12/2003CN1454605A Cough-relieving anti-inflammation drug
11/12/2003CN1454593A Use of total bryostatin for preparing medicine for anti SARS coronavirus
11/12/2003CN1454592A Medical use of andrographolide and its derivatives
11/12/2003CN1454591A Encapsulated preparation of sodium decanoy acetaldehyde
11/12/2003CN1127512C Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127487C Phthalazinone and its use, and drug containing same
11/12/2003CN1127486C Phthalazine derivatives phosphodiesterase 4 inhibitors
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/12/2003CN1127336C Remedy for pulmonary heart
11/11/2003US6645991 αvβ3 integrin inhibitors
11/11/2003US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors
11/11/2003US6645977 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors
11/11/2003US6645976 Indolizine SPLA2inhibitors
11/11/2003US6645968 Potassium channel openers
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003US6645531 Halting, diminishing, or inhibiting the growth of at least one of a bacterium, a fungus; a parasitic microbe, and a virus, which method comprises administering at least one electron active compound
11/11/2003US6645518 Uses for medical devices having a lubricious, nitric oxide-releasing coating
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003CA2272098C Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
11/11/2003CA2144967C Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/06/2003WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091387A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
11/06/2003WO2003091259A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003WO2003091258A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003091256A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND NAD(P)H OXIDASE INHIBITOR CONTAINING THE SAME
11/06/2003WO2003091251A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003091245A1 4,4-disubstituted piperidine derivatives having ccr3 antagonism
11/06/2003WO2003091242A1 Novel thiol derivative, process for producing the same and use thereof
11/06/2003WO2003091229A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
11/06/2003WO2003091227A1 Tachykinin receptor antagonists
1 ... 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 ... 878